| Authors: |
Wang H; Department of Haematology, Division of Investigative Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK., Moon EY; Division of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA., Azouz A; Division of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, 02115, USA., Wu X; Department of Haematology, Division of Investigative Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK., Smith A; Cancer Research UK, London Research Institute, Lincoln's Inn Fields, London, W2A 3PX, UK., Schneider H; Department of Haematology, Division of Investigative Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK.; Division of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, 02115, USA., Hogg N; Cancer Research UK, London Research Institute, Lincoln's Inn Fields, London, W2A 3PX, UK., Rudd CE; Department of Haematology, Division of Investigative Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK. c.rudd@imperial.ac.uk.; Division of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, 02115, USA. c.rudd@imperial.ac.uk.; Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA. c.rudd@imperial.ac.uk.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, 02115, USA. c.rudd@imperial.ac.uk. |
